| Shirley Workman, ANP | |
|
3245 Hospital Dr, Juneau, AK 99801-7809 | |
| (907) 364-4445 | |
| (907) 364-4487 |
| Full Name | Shirley Workman |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 25 Years |
| Location | 3245 Hospital Dr, Juneau, Alaska |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124103825 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 364SP0809X | Clinical Nurse Specialist - Psychiatric/mental Health, Adult | 680 (Alaska) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Southeast Alaska Regional Health Consortium | 1456265362 | 226 |
News Archive
Enzon Pharmaceuticals, Inc. today announced that the first patient has been treated in the Phase 1 study of PEG-SN38 for pediatric cancer patients. PEG-SN38 or EZN-2208 is Enzon's PEGylated form of SN38, the active metabolite of the cancer drug Camptosar® (irinotecan HCl injection). The study is designed to find the recommended dose of PEG-SN38 in pediatric patients. The PEG-SN38 compound is currently being evaluated in Phase 2 studies for metastatic colorectal and breast cancer.
The National Right to Life Committee recently defended Sen. Sam Brownback (R-Kan.) after he was criticized for meeting with former New York City Mayor Rudy Giuliani, who is running for the Republican presidential nomination, to discuss Giuliani's views on abortion, The Hill reports (Bolton, The Hill, 10/26).
CANCER RESEARCH UK scientists have shown that deleting a single gene can increase the average number of tumours in the bowel by 50-fold, according to research published in PNAS today.
Researchers now have a much clearer understanding of how mutations in a single gene can produce the complex cognitive deficits characteristic of Fragile X Syndrome, the most common inherited form of intellectual disability.
› Verified 9 days ago
| Entity Name | Southeast Alaska Regional Health Consortium |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376758037 PECOS PAC ID: 1456265362 Enrollment ID: O20031114000631 |
News Archive
Enzon Pharmaceuticals, Inc. today announced that the first patient has been treated in the Phase 1 study of PEG-SN38 for pediatric cancer patients. PEG-SN38 or EZN-2208 is Enzon's PEGylated form of SN38, the active metabolite of the cancer drug Camptosar® (irinotecan HCl injection). The study is designed to find the recommended dose of PEG-SN38 in pediatric patients. The PEG-SN38 compound is currently being evaluated in Phase 2 studies for metastatic colorectal and breast cancer.
The National Right to Life Committee recently defended Sen. Sam Brownback (R-Kan.) after he was criticized for meeting with former New York City Mayor Rudy Giuliani, who is running for the Republican presidential nomination, to discuss Giuliani's views on abortion, The Hill reports (Bolton, The Hill, 10/26).
CANCER RESEARCH UK scientists have shown that deleting a single gene can increase the average number of tumours in the bowel by 50-fold, according to research published in PNAS today.
Researchers now have a much clearer understanding of how mutations in a single gene can produce the complex cognitive deficits characteristic of Fragile X Syndrome, the most common inherited form of intellectual disability.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Shirley Workman, ANP Po Box 34422, Juneau, AK 99803-4422 Ph: (330) 860-3207 | Shirley Workman, ANP 3245 Hospital Dr, Juneau, AK 99801-7809 Ph: (907) 364-4445 |
News Archive
Enzon Pharmaceuticals, Inc. today announced that the first patient has been treated in the Phase 1 study of PEG-SN38 for pediatric cancer patients. PEG-SN38 or EZN-2208 is Enzon's PEGylated form of SN38, the active metabolite of the cancer drug Camptosar® (irinotecan HCl injection). The study is designed to find the recommended dose of PEG-SN38 in pediatric patients. The PEG-SN38 compound is currently being evaluated in Phase 2 studies for metastatic colorectal and breast cancer.
The National Right to Life Committee recently defended Sen. Sam Brownback (R-Kan.) after he was criticized for meeting with former New York City Mayor Rudy Giuliani, who is running for the Republican presidential nomination, to discuss Giuliani's views on abortion, The Hill reports (Bolton, The Hill, 10/26).
CANCER RESEARCH UK scientists have shown that deleting a single gene can increase the average number of tumours in the bowel by 50-fold, according to research published in PNAS today.
Researchers now have a much clearer understanding of how mutations in a single gene can produce the complex cognitive deficits characteristic of Fragile X Syndrome, the most common inherited form of intellectual disability.
› Verified 9 days ago